Every cell in the body normally has its fixed place as part of a tissue structure. Except for a few cell types, such as blood ...

Successful test in breast cancer patients: the active agent digoxin, a cardiac medication, dissolves clusters of circulating breast cancer cells in the blood, thus reducing the risk of metastases ...

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

In patients with RCC, exceptional response to immunotherapy may be related to clonal neoantigen-driven cytotoxic T-cell ...

Reference: Kurzeder C, Nguyen-Sträuli BD, Krol I, et al. Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial. Nat Med. 2025. doi: 10.1038 ...

Investigators conducted a retrospective review that spanned 10 years with the goals of describing the clinical ...

9, 2024 — Metastasis is responsible for 90 percent of cancer deaths ... Inhibiting a Key Immune Cell Sep. 27, 2024 — Estrogens are known to drive tumor growth in breast cancer cells that ...

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...